Metabolic and weight
Peptides that act on appetite, blood sugar and body weight, led by the GLP-1 medicines.
16 peptides
- In clinical trialsAmycretinUnimolecular GLP-1 and amylin receptor agonistNo single sequence68 WADA banned
- Not approvedAOD-9604Modified growth hormone fragment (research peptide)16 WADA banned
- In clinical trialsCagrilintideLong-acting amylin analog (amylin and calcitonin receptor agonist)37 WADA banned
- ApprovedDulaglutideGLP-1 receptor agonist (Fc fusion protein)31
- ApprovedExenatideGLP-1 receptor agonist39
- ApprovedInsulin (human)Peptide hormone (insulin)51 WADA banned
- ApprovedLiraglutideGLP-1 receptor agonist31
- Approved elsewhereMazdutideGlucagon and GLP-1 receptor dual agonist (oxyntomodulin analog)34
- Not approvedMOTS-cMitochondrial-derived peptide (research peptide)16 WADA banned
- WithdrawnPramlintideAmylin analog37
- In clinical trialsRetatrutideGIP, GLP-1 and glucagon receptor triple agonist39 WADA banned
- ApprovedSemaglutideGLP-1 receptor agonist31
- ApprovedSetmelanotideMelanocortin-4 receptor (MC4R) agonist8
- In clinical trialsSurvodutideGlucagon and GLP-1 receptor dual agonist29 WADA banned
- ApprovedTirzepatideDual GIP and GLP-1 receptor agonist39
- ApprovedTesamorelinGrowth hormone-releasing factor (GHRF) analogue44 WADA banned